The IMS Institute for Healthcare Informatics recently released its 2010 report on the use of medications in the US (you can view it
here). In the list of the top 25 prescribed drugs based on revenue generated, there is only one anti-infective, Atripla, which ranks #23. And you wonder why there are so few new antibiotics in development?
Comments
Post a Comment
Thanks for submitting your comment to the Controversies blog. To reduce spam, all comments will be reviewed by the blog moderator prior to publishing. However, all legitimate comments will be published, whether they agree with or oppose the content of the post.